Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_00173
Species: Homo sapiens
Position : chr3:98678906-98697335
Year: 2025
Title: A novel super-enhancer-driven lncRNA LINC00973 governs head and neck squamous cell carcinoma progression through EN2
Genome Build: hg19
Enhancer Type: Super-enhancer
Condition: Disease
Disease Name: hepatocellular carcinoma
PMID:  41419462
MONDO: MONDO:0007256
Tissue: Liver
Tissue Ontology ID: UBERON:0002107
Cell Source: HepG2
CVCL ID: CVCL_0027
Cell Type: hepatocellular carcinoma cell
Cell Ontology ID: CL:0000182
Experiment Type: Enhancer activity assay, TF binding assay, Functional perturbation assay
High Throughput Method: ChIP-seq, RNA-seq, Hi-C, ATAC-seq
Low Throughput Method: ChIP-RT-qPCR, CRISPRi, Luciferase Reporter Assay, qRT-PCR, Western blot, co-IP
About Target Gene
Target gene : LINC00973
About TF
TF name : FOSL1
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
FOSL1 AP-1 transcription factor network pid 71
FOSL1 Calcineurin-regulated NFAT-dependent transcription in lymphocytes pid 50
FOSL1 Calcium signaling in the CD4+ TCR pathway pid 29
FOSL1 Downstream signaling in naïve CD8+ T cells pid 69
FOSL1 Gene expression of IL2 by AP-1 ( CD4 T cell receptor signaling (JNK cascade) ) inoh 5
FOSL1 Gene expression of IL2 by AP-1 ( CD4 T cell receptor signaling ) inoh 5
FOSL1 JNK cascade ( CD4 T cell receptor signaling (JNK cascade) ) inoh 12
FOSL1 JNK cascade ( CD4 T cell receptor signaling ) inoh 10
FOSL1 TGF-beta signaling pathway panther 88
FOSL1 Validated targets of C-MYC transcriptional activation pid 80
FOSL1 Validated transcriptional targets of AP1 family members Fra1 and Fra2 pid 37
FOSL1 Wnt signaling pathway kegg 135
Enhancer Associated Network
Overlapping Enhancers (hg19)
No overlapping enhancers found in hg19 at this locus.
Expression of Target Genes for the Enhancer